In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...
Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...
Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...
Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ...
Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...
Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...
For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...
Hosted on MSN13d
What to Expect From DexCom's Q4 2024 Earnings ReportValued at $33 billion by market cap, DexCom, Inc. (DXCM) is a global leader in continuous glucose monitoring (CGM) technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback